FEB 22, 2018 9:00 AM PST

Investigating colorectal cancer using epithelial organoid cultures

Speaker

Abstract

DATE: February 22, 2018
TIME: 09:00am PST, 12:00pm EST, 06:00pm CEST(Europe)

Colorectal cancer (CRC) develops during a multi-step process from small lesions of the intestinal epithelium. Genetic mutations in the canonical Wnt signalling pathway are considered to be the initial step of tumour formation. Using 3D organoid technology, tumour organoid cultures from CRC patients can be established. CRC organoids closely recapitulate key properties of the original tumour epithelium, including histological appearance, general gene and protein expression pattern and mutational load. Tumour organoids are amenable to radiation treatment, gene-drug association studies and high-throughput drug screens. Organoid cultures from adjacent healthy colon mucosa that retain the identity of the healthy intestinal epithelium in vitro can also be generated. Sequential introduction of the most commonly mutated CRC genes (APC, P53, KRAS and SMAD4) into healthy colon organoids using CRISPR/Cas9 genome editing technology allows for the modelling of tumorigenesis in vitro. Xenotransplantation of mutated organoids into mice recapitulates critical features of CRC progression and metastasis. In sum, (cancer) organoid technology can be used as experimental tool for basic research as well as diagnostic and therapeutic tool for (personalised) medicine.

Learning Objectives:

  • Understand the advantages of epithelial organoids cultures for (colorectal) cancer modelling.
  • Learn about applications of (colorectal) cancer organoids for experimental, diagnostic and therapeutic use

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
FEB 22, 2018 9:00 AM PST

Investigating colorectal cancer using epithelial organoid cultures


Specialty

Cancer Research

Cell Biology

Molecular Biology

Cell Culture

Cancer Therapeutics

Immunology

Biotechnology

Cancer Diagnostics

Biomarkers

Oncology

Genetics

Biochemistry

Drug Discovery

Molecular Diagnostics

Clinical Diagnostics

Geography

North America54%

Europe28%

Asia10%

South America3%

Africa3%

Oceania1%

Registration Source

Website Visitors70%

Email Promotions13%

WAVE Newsletter Promotion13%

Social Media Promotions2%

Website Banners2%

Client/Sponsor Promotions1%

Job Title

Student16%

Research Scientist14%

Scientist12%

Post Doc9%

Educator/Faculty9%

Facility/Department Manager8%

Executive7%

Medical Laboratory Technician7%

Lab Management6%

Medical Doctor/Specialist6%

Clinical Laboratory Scientist3%

Biologist1%

Veterinarian1%

QC/QA1%

Organization

Academic Institution16%

Research Institute10%

Biotech Company9%

Clinical Laboratory6%

Hospital6%

Life Science Company4%

Government4%

Medical School3%

Medical Center2%

Pharmaceutical Company2%

Non-Profit Organization1%

Industrial Company1%

Consultant1%

Contract Research Organization (Cro)1%

Other4%


Show Resources
Loading Comments...
Show Resources